Institutions & Organismes
WHO stresses urgent need for R&D for drug-resistant TB alongside newly-prioritized antibiotic-resistant pathogens
01 Mars 201728 February 2017 | GENEVA - WHO reaffirms the critical need for research and development (R&D) of new antibiotics to tackle the threat of drug-resistant tuberculosis (TB). |
"Addressing drug-resistant TB research is a top priority for WHO and for the world," said Dr Margaret Chan, WHO Director-General. "More than US$ 800 million per year is currently necessary to fund badly needed research...
- 2016: the year Zika evolved from an emergency into a long-term public health challenge
- Fifth meeting of the Emergency Committee under the International Health Regulations (2005) regarding microcephaly, other neurological disorders and Zika virus
- WHO, Government of China to hold 9th Global conference on health promotion in Shanghai in November
- Opening remarks at the 2016 financing dialogue